Heterogeneity in Psychological Adaptation Patterns and Its Predictive Factors Among Patients with Inflammatory Bowel Disease: A Latent Profile Analysis
Guangyi Xu,Ting Liu,Yunxia Jiang,Yanhong Xu,Taohua Zheng,Xiaona Li
DOI: https://doi.org/10.2147/prbm.s438973
IF: 3.974
2024-01-21
Psychology Research and Behavior Management
Abstract:Guangyi Xu, 1 Ting Liu, 1 Yunxia Jiang, 1 Yanhong Xu, 2 Taohua Zheng, 2 Xiaona Li 3 1 Author affiliations School of Nursing, Qingdao University, Shandong, People's Republic of China; 2 Author affiliations Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Shandong, People's Republic of China; 3 Author Affiliations Endoscopic Diagnosis and Treatment Center, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Qingdao, People's Republic of China Correspondence: Ting Liu, School of Nursing, Qingdao University, 1 Ningde Road, Qingdao, Shandong, 266073, People's Republic of China, Tel +86 15066237573, Email Purpose: To identify the distinct profiles of psychosocial adaptation of Chinese inflammatory bowel disease (IBD) patients and the predictive factors. Patients and Methods: A cross-sectional survey method was used to recruit 263 IBD patients who were treated in a tertiary hospital in Shandong Province from July 2022 to April 2023. The general information questionnaire, Inflammatory Bowel Disease Psychosocial Adaptation Questionnaire, Resilience Scale for Inflammatory Bowel Disease, Chinese Benefit Finding Scale, and Stigma Scale for Chronic Illnesses, Medical Coping Modes Questionnaire and Inflammatory Bowel Disease-Disk were used as the instruments for investigation. Latent profile analysis was conducted with the six dimensions of the IBD Psychosocial Adaptation Questionnaire as the explicit indicators. The predictors of profile membership were analyzed by multinomial logistic regressions. Results: Four profiles of psychosocial adaptation in IBD patients were identified: Low level psychosocial adaptation (14.1%), Medium level psychosocial adaptation – High body image distress (25.5%), Medium level psychosocial adaptation – Low body image distress (30.0%) and High level psychosocial adaptation (30.4%). Compared with Low level psychosocial adaptation group, High level psychosocial adaptation group had a higher level of positive cognition (OR=2.930, 95%IC 0.017– 0.305, p < 0.001) and overall psychological resilience ( OR =1.832, 95%IC 0.000– 0.016, p < 0.001), more health behaviors ( OR = 2.520, 95%IC 0.191– 1.358, p =0.001), a lower level of internal stigma ( OR =0.135, 95%IC 0.043– 0.420, p < 0.001) and overall stigma ( OR =0.010, 95%IC 0.003– 0.118, p =0.001), less acceptance-resignation coping style ( OR =0.055, 95%IC 0.209– 3.200, p < 0.001) and lower disease burden ( OR =0.407, 95%IC 0.298– 0.698, p =0.006). Conclusion: About a half of IBD patients had a medium level of psychosocial adaptation. Psychological resilience, benefit finding, stigma, medical coping styles and disease burden predicted psychosocial adaptation profiles. Healthcare providers need to focus on the heterogeneity of psychosocial adaptation of IBD patients and formulate personalized intervention programs for patients with different profiles to improve their psychosocial adaptation. Keywords: inflammatory bowel disease, latent profile analysis, psychosocial adaptation, benefit finding, resilience, coping, stigma Inflammatory bowel disease (IBD) is a chronic and life-threatening inflammatory disease of the gastrointestinal tissue. 1 There are two main subtypes of IBD, ie, ulcerative colitis (UC) and Crohn's disease (CD). IBD causes intestinal (e.g, abdominal pain, diarrhea, and rectal bleeding) and extra-intestinal symptoms (eg, fatigue, anemia, and arthritis). 2 The global disease burden of IBD has been increasing over the past few decades. 3 The incidence is currently stable in Western countries. 4,5 However, over the past decade, the incidence of IBD in the East has gradually increased, led by Asia and other recently developed and developing countries such as China, Korea and India. 3,6 In China, the number of IBD cases increased by 911, 000 from 1990 to 2019. Due to the large population and the serious aging problem, the burden of IBD in China is expected to continue to grow in the next 25 years, and the number of IBD-related deaths will rise to about 7.57 million in 2044. 7 According to the latest statistics, the hospitalization rate of IBD patients in China showed an upward trend from 2013 to 2018. 8 In 2018, there were 166,000 hospitalized IBD patients in China, and the total hospitalization cost was US $426.37 million. 8 This greatly increases the financial and psychological stress of patients and imposes a huge financial and resource burden on the Chinese healthcare system. 5,9 In addition, IBD is usually diagnosed i -Abstract Truncated-
psychology, clinical, multidisciplinary